Podcast: The Myth of Average: Time for Change
AiArthritis Voices Podcast, April 3, 2022
Tiffany Westrich-Robertson, CEO of AiArthritis and person living with non-radiographic axial spondyloarthritis, speaks with NPC's John O'Brien about the topic of importance of innovation and treatment access in this podcast episode.
AMCP 2022: High Out-of-Pocket Costs Are Associated with Nonadherence Among Patients Taking Oral Cancer Drugs
Managed Healthcare Executive, March 31, 2022
This articles describes NPC-sponsored research presented at the AMCP annual meeting that shows that almost half of cancer patients on oral therapies are nonadherent.
Michael Ciarametaro Talks About Balancing Drug Price Reform With Encouraging Innovation
American Journal of Managed Care, March 30, 2022
In a video interview, Michael Ciarametaro, NPC's vice president of research, discusses the balance between lowering drug prices and encouraging innovation in new drug classes for serious diseases.
AMCP 2022: Michael Ciarametaro of National Pharmaceutical Council Talks Gene Therapy, Medicaid Best Price Rule
Managed Healthcare Executive, March 30, 2022
NPC's Michael Ciarametaro speaks about gene therapy and the Medicaid Best Price Rule in a video interview during the annual AMCP conference in Chicago.
Price Transparency Healthcare Policies Reduce Out-Of-Pocket Costs
PharmaNewsIntelligence, March 18, 2022
NPC President and CEO John M. O'Brien weighs in on issues around the importance of price transparency in health care and reducing patient out-of-pocket costs to improve access to medicines.
National Pharmaceutical Council Executive to Give Hartman Lecture
The Oxford Eagle (Miss.), March 8, 2022
The local Oxford, Miss., newspaper reports on NPC President and CEO John M. O’Brien presenting the annual Charles W. Hartman Memorial Lecture on Friday, March 11, at the University of Mississippi.
ICER to Develop Annual Drug Price Hike Reports For California
InsideHealthPolicy, March 4, 2022 (subscription required)
An article about the Institute for Clinical and Economic Review (ICER) developing two reports for California cites NPC's concerns about ICER's flawed report methodology and notes that NPC President and CEO John O'Brien cautioned health policymakers in California against using the reports for policies that could harm patients.
Adopting Good Practices for High-Deductible Health Plans Can Help Employers Build Better Health Benefits
American Journal of Accountable Care, March 4, 2022
NPC and Gallagher Research & Insights discuss results from a survey demonstrating that employers are receptive to the idea of adopting good practices for health savings account-eligible high-deductible health plans (HDHPs) and, in many cases, are already implementing them.
Experts Discuss How Employers Can Take on HSA HDHP Challenges While Encouraging Value-Based Care
American Journal of Managed Care, February 20, 2022
AJMC provides highlights from part 2 of a two-part webinar series, hosted by the National Alliance of Healthcare Purchaser Coalitions and moderated by NPC's Kimberly Westrich, focused on employer opportunities for improving value and crafting smarter deductibles in HSA-eligible HDHPs.
9 Employer Best Practices for High Deductible Health Plan Design
HealthPayerIntelligence, February 16, 2022
This article focuses on the recent report from NPC and Gallagher Research & Insights on ways employers can more effectively implement high-deductible health plans.
How Employers Can Leverage Value, Health Equity Incentives to Address Health Plan Affordability Concerns
American Journal of Managed Care, February 6, 2022
AJMC provides highlights from part 1 of a two-part webinar series, hosted by the National Alliance of Healthcare Purchaser Coalitions and featuring NPC's Kimberly Westrich, addressing issues in health care coverage affordability and how equitable health benefits and value-based design can reduce cost while improving employee engagement.
The Myth of Average: Why Individual Patient Differences Matter
American Journal of Managed Care, January 19, 2022
AJMC featured on its website NPC's newly updated booklet The Myth of Average: Why Individual Patient Differences Matter, which explores the barriers patients face when navigating the health care system.
New CMS Rule Fails to Fix Medicaid Best Price
BioCentury (subscription required), January 14, 2022
NPC's Health Affairs Forefront article "Medicaid Best Price Volatility Could Inhibit Payment Innovation" was featured in this BioCentury piece on Medicaid best price legislation impeding patient access to expensive gene therapies.
Addressing Access Burdens
Pharmaceutical Executive, January 11, 2022
NPC President and CEO John M. O'Brien discusses the increasing barriers for patients to receiving needed therapies and how pharmaceutical companies are reaching out to employers directly to talk about health benefits.
Video: Kimberly Westrich on Micro-, Macro-Level Approaches to Improve Value-Based Benefit Design
American Journal of Managed Care, January 6, 2022
The final video in a four-part series with NPC Vice President of Health Services Research Kimberly Westrich addresses future opportunities for growth regarding value-based benefits. View part one, part two, and part three of the video series.
NPC Appoints Sharon Phares Chief Scientific Officer
UNC Gillings School of Public Health, January 22, 2022
Pharmacy Times, January 18, 2022
HealthEconomics.com, January 11, 2022
STAT News, January 7, 2022
Fierce Biotech, January 7, 2022
BioSpace, January 7, 2022
Chain Drug Review, January 4, 2022
Contract Pharma, January 4, 2022
Politico Pulse, Prescription Pulse and Playbook newsletters, January 4, 2022
Pharmacy Outlook: John O’Brien, NPC
Chain Drug Review, January 3, 2022
To kick off the new year, NPC's John M. O’Brien writes in Chain Drug Review about the need for a more informed public discussion about the role that prescription drugs play in our health care system and in improving the lives of patients.